Super Memory Formula

How To Prevent Alzheimer Naturally

Get Instant Access

Bian, F., Nath, R., Sobocinski, G., Booher, R.N., Lipinski, W.J., Callahan, M.J., et al. (2002). Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol 446, 257-266.

Boncristiano, S., Calhoun, M.E., Howard, V., Bondolfi, L., Kaeser, S.A., Wiederhold, K.H., et al. (2005). Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice. Neurobiol Aging 26, 607-613.

Borchelt, D.R., Ratovitski, T., van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., et al. (1997). Accelerated amyloid deposition in the brains of transgenic mice coex-pressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939-945.

Borchelt, D.R., Thinakaran, G., Eckman, C.B., Lee, M.K., Davenport, F., Ratovitsky, T., et al. (1996). Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.

Bussiere, T., Friend, P.D., Sadeghi, N., Wicinski, B., Lin, G.I., Bouras, C., et al. (2002). Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 112, 75-91.

Callahan, M.J., Lipinski, W.J., Bian, F., Durham, R.A., Pack, A., and Walker, L.C. (2001). Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice. Am J Pathol 158, 1173-1177.

Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., et al. (1997). Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid betaprotein in both transfected cells and transgenic mice. Nat Med 3, 67-72.

Colle, M.A., Hauw, J.-J., Crespau, F., Uchihara, T., Akiyama, T., Checler, F., et al. (2000). Vascular and parenchymal Abeta deposition in the aging dog: Correlation with behavior. Neurobiol Aging 21, 695-704.

Cummings, J.L. (2004). Alzheimer's disease. N Engl J Med 351, 56-67.

Davis, J., Xu, F., Deane, R., Romanov, G., Previti, M., Zeigler, K., et al. (2004). Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem 279, 20296-20306.

DeMattos, R.B. (2004). Apolipoprotein E Dose-dependent modulation of beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease. J Mol Neurosci 23, 255-262.

Dermaut, B., Kumar-Singh, S., Engelborghs, S., Theuns, J., Rademakers, R., Saerens, J., et al. (2004). A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 55, 617-626.

Driscoll, M., and Gerstbrein, B. (2003). Dying for a cause: Invertebrate genetics takes on human neurodegeneration. Nat Rev Genet 4, 181-194.

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.M., Perez-tur, J., et al. (1996). Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.

Eikelenboom, P., Bate, C., Van Gool, W.A., Hoozemans, J.J., Rozemuller, J.M., Veerhuis, R., and Williams, A. (2002). Neuroinflammation in Alzheimer's disease and prion disease. Glia 40, 232-239.

Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D., and Link, C.D. (2002). Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci USA 99, 9439-9444.

Frackowiak, J., Miller, D.L., Potempska, A., Sukontasup, T., and Mazur-Kolecka, B. (2003). Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice. J Neuropathol Exp Neurol 62, 685-696.

Frackowiak, J., Potempska, A., LeVine, H., Haske, T., Dickson, D., and Mazur-Kolecka, B. (2005). Extracellular deposits of Abeta produced in cultures of Alzheimer disease brain vascular smooth muscle cells. J Neuropathol Exp Neurol 64, 82-90.

Frautschy, S.A., Yang, F., Calderon, L., and Cole, G.M. (1996). Rodent models of Alzheimer's disease: Rat Abeta infusion approaches to amyloid deposits. Neurobiol Aging 17, 311-321.

Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., et al. (1995). Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523-527.

Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B.A. (1998). Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4, 827-831.

Gotz, J., Chen, F., van Dorpe, J., and Nitsch, R.M. (2001). Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495.

Gotz, J., Schild, A., Hoerndli, F., and Pennanen, L. (2004). Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: Insight from transgenic mouse and tissue-culture models. Int J Dev Neurosci 22, 453-465.

Hardy, J., and Selkoe, D.J. (2002). The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.

Hauw, J.-J., and Duyckaerts, C. (2001). Alzheimer's Disease. In Duckett, S., and De La Torre, J.C. (Eds.), Pathology of the Aging Human Nervous System, pp. 207-263. New York: Oxford University Press.

Herzig, M.C., Winkler, D.T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S.D., et al. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7, 954-960.

Hof, P.R., Gilissen, E.P., Sherwood, C.C., Duan, H., Lee, P.W.H., Delman, B.N., et al. (2002). Comparative neuropathology of brain aging in primates. In Erwin, J.M., and Hof, P.R. (Eds.), Aging in Nonhuman Primates, pp. 130-154. Basel: Karger.

Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., et al. (1998). Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100.

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., et al. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.

Jucker, M., Walker, L.C., Martin, L.J., Kitt, C.A., Kleinman, H.K., et al. (1992). Age-associated inclusions in normal and transgenic mouse brain. Science 255, 1443-1445.

Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W., and Glabe, C.G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.

Kirik, D., Annett, L., Burger, C., Muzyczka, N., Mandel, R.J., and Bjorklund, A. (2003). Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: A new primate model of Parkinson's disease. PNAS 100, 2884-2889.

Klunk, W.E., Lopresti, B.J., Debnath, M.L., Holt, D.P., Wang, Y., Huang, G.-F., et al. (2004). Amyloid deposits in transgenic PS1/APP mice do not bind the amyloid PET tracer, PIB, in the same manner as human brain amyloid. Neurobiology of Aging 25, 232.

Lacor, P.N., Buniel, M.C., Chang, L., Fernandez, S.J., Gong, Y., Viola, K.L., et al. (2004). Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24, 10191-10200.

Lamb, B.A., Bardel, K.A., Kulnane, L.S., Anderson, J.J., Holtz, G., Wagner, S.L., et al. (1999). Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice. Nat Neurosci 2, 695-697.

Lee, V.M., Goedert, M., and Trojanowski, J.Q. (2001). Neurodegenerative tauopathies. Annu Rev Neurosci 24, 1121-1159.

Lee, V.M., Kenyon, T.K., and Trojanowski, J.Q. (2005). Transgenic animal models of tauopathies. Biochim Biophys Acta 1739, 251-259.

Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., et al. (2001). Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491.

Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., et al. (2000). Neurofi-brillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25, 402-405.

Marjaux, E., Hartmann, D., and De Strooper, B. (2004). Presenilins in memory, Alzheimer's disease, and therapy. Neuron 42, 189-192.

Mattson, M.P. (2002). Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J Neurovirol 8, 539-550.

Milgram, N.W., Head, E., Zicker, S.C., Ikeda-Douglas, C.J., Murphey, H.L., Muggenburg, B., et al. (2005). Learning ability in aged beagle dogs is preserved by behavioral enrichment and dietary fortification: A two-year longitudinal study. Neurobiol Aging 26, 77-90.

Oddo, S., Billings, L., Kesslak, J.P., Cribbs, D.H., and LaFerla, F.M. (2004). Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron 43, 321-332.

Oddo, S., Caccamo, A., Kitazawa, M., Tseng, B.P., and LaFerla, F.M. (2003a). Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070.

Oddo, S., Caccamo, A., Shepherd, J.D., Murphy, M.P., Golde, T.E., Kayed, R., et al. (2003b). Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.

Peel, A.L., and Bredesen, D.E. (2003). Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol Dis 14, 52-62.

Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 17, 525-530.

Rankin, C.H. (2004). Invertebrate learning: What can't a worm learn? Curr Biol 14, R617-618.

Reilly, J.F., Games, D., Rydel, R.E., Freedman, S., Schenk, D., Young, W.G., et al. (2003). Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model. Proc Natl Acad Sci USA 100, 4837-4842.

Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., and Holton, J.L. (2003). Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62, 885-898.

Rohrbough, J., O'Dowd, D.K., Baines, R.A., and Broadie, K. (2003). Cellular bases of behavioral plasticity: Establishing and modifying synaptic circuits in the Drosophila genetic system. J Neurobiol 54, 254-271.

Schonheit, B., Zarski, R., and Ohm, T.G. (2004). Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 25, 697-711.

Schwab, C., Hosokawa, M., and McGeer, P L. (2004). Trans-genic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease. Exp Neurol 188, 52-64.

Siman, R., Reaume, A.G., Savage, M.J., Trusko, S., Lin, Y.G., Scott, R.W., and Flood, D.G. (2000). Presenilin-1 P264L knock-in mutation: Differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci 20, 8717-8726.

Siwak, C.T., Tapp, P.D., Head, E., Zicker, S.C., Murphey, H.L., Muggenburg, B.A., et al. (2005). Chronic antioxidant and mitochondrial cofactor administration improves discrimination learning in aged but not young dogs. Prog Neuropsychopharmacol Biol Psychiatry 29, 461-469.

Studzinski, C.M., Araujo, J.A., and Milgram, N.W. (2005). The canine model of human cognitive aging and dementia: Pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 29, 489-498.

Tapp, P.D., Siwak, C.T., Gao, F.Q., Chiou, J.Y., Black, S.E., Head, E., et al. (2004). Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 24, 8205-8213.

Tesseur, I., Van Dorpe, J., Spittaels, K., Van den Haute, C., Moechars, D., and Van Leuven, F. (2000). Expression of human apolipoprotein E4 in neurons causes hyperpho-sphorylation of protein tau in the brains of transgenic mice. Am J Pathol 156, 951-964.

Torp, R., Head, E., Milgram, N.W., Hahn, F., Ottersen, O.P., and Cotman, C.W. (2000). Ultrastructural evidence of fibrillar beta-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains. Neuroscience 96, 495-506.

Vloeberghs, E., Van Dam, D., Engelborghs, S., Nagels, G., Staufenbiel, M., and De Deyn, P.P. (2004). Altered circadian locomotor activity in APP23 mice: A model for BPSD disturbances. Eur J Neurosci 20, 2757-2766.

Voytko, M.L., and Tinkler, G.P. (2004). Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause. Front Biosci 9, 1899-1914.

Walker, L.C., Callahan, M.J., Bian, F., Durham, R.A., Roher, A.E., and Lipinski, W.J. (2002). Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23, 1241-1247.

Walker, L.C., and Cork, L.C. (1999). The neurobiology of aging in nonhuman primates. In Terry, R.D., Katzman, R., Bick, K.L., and Sisodia, S.S. (Eds.), Alzheimer Disease, pp. 233-243. Philadelphia: Lippincott Williams and Wilkins.

Walker, L.C., Ibegbu, C.C., Todd, C.W., Robinson, H.L., Jucker, M., LeVine, H.R., and Gandy, S. (2005). Emerging prospects for the disease-modifying treatment of Alzheimer's disease. Biochem Pharmacol 69, 1001-1008.

Walker, M.L. (1995). Menopause in female rhesus monkeys. Am J Primatology 35, 59-71.

Walsh, D.M., and Selkoe, D.J. (2004). Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11, 213-228.

Wegiel, J., Wisniewski, H.M., Dziewiatkowski, J., Tarnawski, M., Nowakowski, J., Dziewiatkowska, A., and Soltysiak, Z. (1995). The origin of amyloid in cerebral vessels of aged dogs. Brain Res 705, 225-234.

Wisniewski, T., Dowjat, W.K., Buxbaum, J.D., Khorkova, O., Efthimiopoulos, S., Kulczycki, J., et al. (1998). A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 9, 217-221.

Was this article helpful?

0 0


The Stages Of A Woman’s Life Are No Longer A Mystery. Get Instant Access To Valuable Information On All The Phases Of The Female Body From Menstruation To Menopause And Everything In Between.

Get My Free Ebook

Post a comment